[HTML][HTML] Clinical insights into the cross-link between mood disorders and type 2 diabetes: a review of longitudinal studies and Mendelian randomisation analyses

C Possidente, G Fanelli, A Serretti, C Fabbri - … & Biobehavioral Reviews, 2023 - Elsevier
Mood disorders and type 2 diabetes mellitus (T2DM) are prevalent conditions that often co-
occur. We reviewed the available evidence from longitudinal and Mendelian randomisation …

[HTML][HTML] Mortality and lithium-protective effects after first-episode mania diagnosis in bipolar disorder: a nationwide retrospective cohort study in Taiwan

AF Carvalho, CW Hsu, E Vieta, M Solmi… - Psychotherapy and …, 2024 - karger.com
Introduction: This study aimed to estimate all-cause mortality in patients after a first-episode
mania (FEM) and examine whether six guideline-recommended medications can reduce …

Lithium, the gold standard drug for bipolar disorder: analysis of current clinical studies

M Airainer, R Seifert - Naunyn-Schmiedeberg's Archives of Pharmacology, 2024 - Springer
Lithium is the gold standard drug in the treatment of bipolar disorder. Despite increasing
scientific interest, relatively few patients with bipolar disorder receive lithium therapy. Lithium …

Pharmacological treatment of bipolar disorder and risk of diabetes mellitus: A nationwide study of 30,451 patients

C Rohde, O Köhler‐Forsberg, AA Nierenberg… - Bipolar …, 2023 - Wiley Online Library
Objective While treatment with antipsychotics and antiepileptics have been associated with
an increased risk of diabetes mellitus (DM), lithium may have the opposite effect via …

Association of thyroid function with abnormal lipid metabolism in young patients with first-episode and drug naïve major depressive disorder

J Hu, Y Ji, X Lang, XY Zhang - Frontiers in Psychiatry, 2023 - frontiersin.org
Introduction Abnormal lipid metabolism in patients with major depressive disorder (MDD)
has received increasing attention. The coexistence of MDD and abnormal thyroid function …

Lithium produces bi-directionally regulation of mood disturbance, acts synergistically with anti-depressive/-manic agents, and did not deteriorate the cognitive …

C Zhuo, C Zhou, H Tian, Q Li, J Chen, L Yang… - Translational …, 2022 - nature.com
Lithium (Li) is a well-established mood disorder treatment and may be neuroprotective. Bi-
directional regulation (ie affecting manic symptoms and depressive symptoms) by Li has not …

Lithium bidirectionally regulates depression-and mania-related brain functional alterations without worsening cognitive function in patients with bipolar disorder

C Zhuo, G Chen, J Chen, H Tian, X Ma, Q Li… - Frontiers in …, 2022 - frontiersin.org
Lithium monotherapy has been proposed to have antidepressant and antimanic effects in
patients with bipolar disorder (BP). However, so far, it is lack of evidence to support this …

The vascular-Bipolar link

BI Goldstein, JG Fiedorowicz - Journal of affective …, 2023 - pubmed.ncbi.nlm.nih.gov
The vascular - Bipolar link The vascular - Bipolar link J Affect Disord. 2023 Jul 1:332:201-202.
doi: 10.1016/j.jad.2023.04.001. Epub 2023 Apr 5. Authors Benjamin I Goldstein 1 , Jess G …

[PDF][PDF] Metabolic Alterations and Drug Interactions: The Role of the Association between Antipsychotics/Mood Stabilizers and Cognitive Deficits

N Fiorentino, A Soddu, B Solomita, G Rosato… - Psychiatria …, 2022 - neamente.com
Alterations in the metabolic profile are one of the main consequences of the use of drug
therapies in psychiatric patients. In particular, dysfunction of the metabolic profile (lipid and …

Lítio versus quetiapina no transtorno afetivo bipolar

LS Dos Santos, AS Corrêa, EGS da Silva… - Revista Eletrônica …, 2023 - acervomais.com.br
Objetivo: Investigar na literatura científica se há melhor tratamento para Transtorno Afetivo
Bipolar (TAB) ao comparar os antipsicóticos lítios e quetiapina, além de entender mais …